[2-cyclopropyl-4-[(3,7-dimethyl-1-bicyclo[3.3.1]nonanyl)methoxy]-6-fluorophenyl]-(3-fluoropyrrolidin-1-yl)methanone
C26H35F2NO2 — CID 144996011
Data last refreshed: (MolForge compound catalog, from PubChem)
About [2-cyclopropyl-4-[(3,7-dimethyl-1-bicyclo[3.3.1]nonanyl)methoxy]-6-fluorophenyl]-(3-fluoropyrrolidin-1-yl)methanone
[2-cyclopropyl-4-[(3,7-dimethyl-1-bicyclo[3.3.1]nonanyl)methoxy]-6-fluorophenyl]-(3-fluoropyrrolidin-1-yl)methanone (PubChem CID 144996011) has the molecular formula C26H35F2NO2 and a molecular weight of 431.57 g/mol. Its IUPAC name is [2-cyclopropyl-4-[(3,7-dimethyl-1-bicyclo[3.3.1]nonanyl)methoxy]-6-fluorophenyl]-(3-fluoropyrrolidin-1-yl)methanone.
Molecular Properties
| Compound Name | [2-cyclopropyl-4-[(3,7-dimethyl-1-bicyclo[3.3.1]nonanyl)methoxy]-6-fluorophenyl]-(3-fluoropyrrolidin-1-yl)methanone |
|---|---|
| PubChem CID | 144996011 |
| Molecular Formula | C26H35F2NO2 |
| Molecular Weight | 431.57 g/mol |
| Exact Mass | 431.26 |
| IUPAC Name | [2-cyclopropyl-4-[(3,7-dimethyl-1-bicyclo[3.3.1]nonanyl)methoxy]-6-fluorophenyl]-(3-fluoropyrrolidin-1-yl)methanone |
| SMILES | CC1CC2CC(C)CC(COc3cc(F)c(C(=O)N4CCC(F)C4)c(C4CC4)c3)(C1)C2 |
| InChI | InChI=1S/C26H35F2NO2/c1-16-7-18-8-17(2)12-26(11-16,13-18)15-31-21-9-22(19-3-4-19)24(23(28)10-21)25(30)29-6-5-20(27)14-29/h9-10,16-20H,3-8,11-15H2,1-2H3 |
| InChIKey | OEBNOJXCWHSQOY-UHFFFAOYSA-N |
| XLogP | 6.12 |
| TPSA | 29.54 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 431.57 |
| LogP ≤ 5 | 6.12 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 2 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 144996011 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.